CSIMarket
 


Axim Biotechnologies Inc   (AXIM)
Other Ticker:  
 

Axim Biotechnologies Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Axim Biotechnologies Inc in the third quarter 2023?
Due to the lack of equity, it was not possible to calculate Axim Biotechnologies Inc 's return on equity (ROE) in its third quarter 2023

What is ROE?



Return On Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -7 -9 -7 -6 -13
Return On Equity (TTM) - - - - -
AXIM's Total Ranking # # # # #
Equity (TTM) in Millions -6 -10 -6 -5 -4
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





AXIM Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Equity in Millions -5 -2 2 -7 -6
Y / Y Equity Change - - - - -
Net Income in Millions -6 -16 -6 -6 -7
Y / Y Net Income Change - - - - -
Return On Equity - - -409.36 % - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
AXIM's' Return on Equity at Yahoo Finance
AXIM's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for AXIM's Competitors
Return On Equity for Axim Biotechnologies Inc 's Suppliers
Roe for AXIM's Customers




Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector ROE
Therapeuticsmd Inc   216.13 %
Vascular Biogenics Ltd   184.59 %
Scynexis Inc   182.33 %
Biomx Inc   173.61 %
Halozyme Therapeutics Inc   159.73 %
Amgen Inc   129.08 %
Janone Inc   101.35 %
Science 37 Holdings Inc   88.15 %
Mei Pharma Inc   87.24 %
Idexx Laboratories Inc  85.68 %
Dariohealth Corp   76.80 %
Malachite Innovations Inc   76.59 %
Davita Inc   76.14 %
Tenax Therapeutics Inc   69.85 %
Medpace Holdings Inc   68.48 %
Ocuphire Pharma Inc   65.54 %
Protalix Biotherapeutics inc   62.80 %
Cv Sciences Inc   56.96 %
Omeros Corp  54.32 %
Elite Pharmaceuticals Inc   54.25 %
Entera Bio Ltd   51.91 %
Vaso Corporation  49.23 %
Zoetis Inc   49.00 %
Enzo Biochem Inc  47.55 %
Star Equity Holdings Inc   47.18 %
Abbvie inc   46.90 %
Johnson and Johnson  46.90 %
Innoviva Inc   46.40 %
Eli Lilly And Company  44.81 %
Zymeworks Inc   44.62 %


Date modified: 2023-11-21T23:05:36+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com